featured
Effect of Once-Weekly Exenatide on eGFR Slope Depends on Baseline Renal Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Once-Weekly Exenatide on eGFR Slope Depends on Baseline Renal Risk: A Post-Hoc Analysis of the EXSCEL Trial
Diabetes Obes Metab 2020 Aug 17;[EPub Ahead of Print], ABV Aart-van der Beek, LE Clegg, RC Penland, DW Boulton, CD Sjöström, RJ Mentz, RR Holman, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.